Serum Progesterone is the Best Hormone to Draw
For a 27-year-old woman with a Mirena IUD, serum progesterone is the most clinically useful hormone to assess ovarian function and determine whether ovulation is occurring. This is the single most informative test because the levonorgestrel-releasing IUD (LNG-IUD) primarily exerts local endometrial effects while having variable systemic hormonal impacts.
Rationale Based on Mechanism of Action
The Mirena IUD works predominantly through local endometrial suppression rather than complete ovarian suppression. Research demonstrates that:
- Ovulation persists in the majority of users: After long-term use (6 years), 78.5% of women maintain ovulatory cycles 1
- During the first year of use, approximately 44.8% of cycles remain ovulatory 2
- Complete ovarian suppression is rare, occurring in only 14.3% of cycles even after extended use 1
Why Progesterone is the Optimal Choice
Progesterone measurement in the mid-luteal phase (day 21 of a 28-day cycle, or 7 days before expected menses) directly confirms ovulation. A progesterone level >3 ng/mL indicates ovulation occurred, while levels >10 ng/mL confirm adequate luteal function 1, 2.
This single test provides critical information:
- Confirms ovarian function despite the IUD
- Distinguishes between ovulatory and anovulatory cycles
- Helps explain bleeding patterns (amenorrhea with ovulatory cycles indicates local endometrial effect rather than ovarian suppression) 2
Alternative Hormones Have Limited Utility
Estradiol (E2)
- Shows high individual variability with LNG-IUD use
- Follicular development continues normally in most users 1, 3
- Less specific for determining ovulatory status
- Correlation with levonorgestrel levels exists but doesn't change clinical management 2
LH and FSH
- Remain largely unaffected by LNG-IUD 4, 3
- The IUD does not significantly alter follicular maturation or ovulation timing 3
- These tests add minimal clinical value beyond progesterone
Levonorgestrel Levels
- Not routinely clinically useful
- Levels vary widely between individuals (mean 260-470 pmol/L) 1, 2
- Higher levels correlate with anovulation but don't change management 2
Clinical Context Matters
The indication for hormonal testing should guide the specific approach:
- For amenorrhea evaluation: Progesterone confirms whether amenorrhea is due to local endometrial suppression (with ovulation) versus anovulation
- For irregular bleeding: Progesterone helps distinguish luteal insufficiency from anovulatory bleeding patterns 2
- For fertility assessment: Progesterone documents return of ovarian function
Important Caveats
The CDC 2024 guidelines 5 specify that no routine hormonal testing is required before LNG-IUD initiation or during routine follow-up. Testing should only be performed when clinically indicated for specific symptoms or concerns.
If pregnancy is a concern, beta-hCG takes precedence over any other hormonal assessment, as the LNG-IUD has a pregnancy rate <1% but breakthrough pregnancies can occur 6, 7.